Isleworth Healthcare Acquisition Corporation Common stock
ISLE
ISLE was delisted on the 26th of August, 2022.
67 hedge funds and large institutions have $164M invested in Isleworth Healthcare Acquisition Corporation Common stock in 2021 Q1 according to their latest regulatory filings, with 67 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
64.75% more ownership
Funds ownership: 0% → 64.75% (+65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$14.4M |
| 2 |
BL
Bleichroeder LP
New York
|
+$9.66M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$8.24M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$8.22M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.21M |
Top Sellers
ISLE Hedge Fund Activity: Q1 2021 in Review
67 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Isleworth Healthcare Acquisition Corporation Common stock (ISLE) for Q1 2021, worth a combined $164M.
Buyers outnumbered sellers: 67 funds opened new ISLE positions and 0 closed out — a net gain of 67 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $14.4M.
- 67 institutional investors held Isleworth Healthcare Acquisition Corporation Common stock (ISLE) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $164M of Isleworth Healthcare Acquisition Corporation Common stock stock for Q1 2021.
- 67 funds opened new Isleworth Healthcare Acquisition Corporation Common stock positions in Q1 2021 and 0 closed out, a net change of +67 holders.
- The largest Isleworth Healthcare Acquisition Corporation Common stock buyer in Q1 2021 was Glazer Capital LLC, an estimated $14.4M added.
Based on aggregated 13F filings for Q1 2021.